RegWardenFDA facility compliance records
Recall

Class II — Terumo Cardiovascular Systems Corporation

Recalling firmTERUMO CARDIOVASCULAR SYSTEMS CORP.
Registered facilityTERUMO CARDIOVASCULAR SYSTEMS CORPORATION (the firm's only registered facility)
ClassificationClass II
StatusTerminated
ReasonTerumo Cardiovascular Systems Corporation has received complaints indicating that the Sarns Centrifugal Pump (disposable pump heads) have exhibited leaks. The leaks were detected during priming of the bypass circuit and during CPB procedures. In each of the reported incidents, there were no reports of patient injury as a result of the centrifugal pump leaks. Terumo Cardiovascular System's investigation into the incident has identified the cause of the leaks to be cracks in both the Top Housing and Magnet Back Housing of the pump. When the cracks cause the housing to become compromised, it is possible for fluid to leak from the pump head.
ProductThe Sarns Centrifugal Pump is a single use device sterilized by ethylene oxide gas. The device is sold single sterile in cartons of 8 units, or may be provided in bulk, non-sterile to another Terumo location for inclusion in Cardiovascular Procedure Kits. Cardiovascular Procedure kits are packaged individually.
Quantity579 units have entered into the distribution chain
DistributionTerumo CVS has identified 33 domestic consignees and 0 international consignee that are affected by this recall
Initiated2015-05-27
Classified2017-02-22
Terminated2017-02-23
Recall numberZ-1235-2017
InitiationVoluntary: Firm initiated

Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this recall record at FDA → (opens in a new tab)

Cite this record

RegWarden. “Class II recall — Terumo Cardiovascular Systems Corporation (Z-1235-2017).” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/recall/76386/

Not open yet

Alerts for TERUMO CARDIOVASCULAR SYSTEMS CORP.

Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.

Planned

Want a one-page facility brief?

A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.